Navigation Links
New consensus on work-related asthma
Date:9/23/2008

In a new consensus statement, the American College of Chest Physicians offers guidance on the diagnosis and treatment of work-related asthma (WRA), a chronic respiratory condition that includes occupational asthma and work-exacerbated asthma (WEA) and affects as many as 25 percent of adults with asthma. Published as a supplement to the September issue of CHEST, the consensus statement, updated from 1995, places new emphasis on

  1. preventive measures, including better control of exposures;
  2. the need for a combination of diagnostic testing; and
  3. the importance of obtaining a full medical and occupational history in patients with suspected WRA.

The statement also places greater consideration on the diagnosis and management of WEA, which is preexisting or concurrent asthma that is worsened by work-related conditions. Developed by an expert panel of specialists in allergy, pulmonary medicine, and occupational medicine, the consensus statement provides supplemental materials, including a worker/workplace fact sheet and physician flow sheets to help physicians and other health-care providers diagnose and manage WRA. For more information related to the ACCP consensus statement on work-related asthma, visit www.chestjournal.org.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Page: 1

Related biology technology :

1. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
2. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
3. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
4. New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
5. Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows
6. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
7. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
8. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
9. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
10. Drug Reduces Airway Mucus in Preclinical Asthma Model
11. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells Group and the ... as other research and development initiatives for potential stem cell protocol management for 2016 ... Cells Group executives began meeting to establish a working agenda and foster initiatives to ...
(Date:4/26/2016)... ... April 27, 2016 , ... Cameron Cushman ... as an associate in the firm’s Intellectual Property practice group. , Clients turn ... patent applications. He has an electrical engineering and computer engineering background, and experience ...
(Date:4/26/2016)... ... April 26, 2016 , ... Heidelberg Instruments, ... latest technology innovation for its Volume Pattern Generator (VPG) line of lithography systems. ... advanced photomasks as well as a solution for mid volume direct write lithography ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., a biopharmaceutical research ... financing. Healthy investor interest drove significant oversubscription of the original $1.5M target. ... biosimilars, to the advanced preclinical stages. , Chief Executive Officer and President, Darryl ...
Breaking Biology Technology:
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):